Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation

Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation

Patients with aortocoronary bypass surgery generelly have a severe, advanced coronary atherosclerosis. An intensive risk-factor management should be of special importance in these patients. However, cholesterol treatment goals are the same for operated or non-operated patients with coronary artery d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2006-01, Vol.95, p.i78
Hauptverfasser: von Hodenberg, E, Breidenbach, Th, Melichercik, J
Format: Artikel
Sprache:ger
Schlagworte:
Atherosclerosis
Cardiovascular disease
Coronary vessels
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page i78
container_title Clinical research in cardiology
container_volume 95
creator von Hodenberg, E
Breidenbach, Th
Melichercik, J
description Patients with aortocoronary bypass surgery generelly have a severe, advanced coronary atherosclerosis. An intensive risk-factor management should be of special importance in these patients. However, cholesterol treatment goals are the same for operated or non-operated patients with coronary artery disease. Effective cholesterol lowering does not only decrease the progression of atherosclerosis in native coronary vessels but also helps to prevent the development of atherosclerosis in venous bypass grafts. Clinical studies demonstrated that this leads to an improvement of clinical endpoints. Unfortunately we know from registries, that even in bypass patients recommended guidelines for cholesterol lowering are often not followed.[PUBLICATION ABSTRACT]
doi_str_mv 10.1007/s00392-006-1116-x
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_885042112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434385451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c752-b315dcf4a1b783ac7dc257527f2ce71f72deb6e4513f7db156159a1006d92f6a3</originalsourceid><addsrcrecordid>eNo9T01LAzEQDaJgrf4Ab4v3aCbZJLtHWz-hoIfitWSTid22JGuyC_rvjSie5vFm3scQcgnsGhjTN5kx0XLKmKIAoOjnEZlBo4Ay1fLjf9zUp-Qs5x1jEpioZ-TtrsdqgQ6ncQrvlcNULbfxgHnE1IeMYf9Dd9hXr2bsMYwYqmDstjIxjXEfUwwmFdHiazA5xwFTOYvhnJx4c8h48TfnZP1wv14-0dXL4_PydkWtlpx2AqSzvjbQ6UYYq53lsiy05xY1eM0ddgprCcJr14FUIFtT_lWu5V4ZMSdXv7ZDih9TKb3ZxSmFkrhpGslqDsDFN1XtVDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>885042112</pqid></control><display><type>article</type><title>Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation</title><source>SpringerLink Journals - AutoHoldings</source><creator>von Hodenberg, E ; Breidenbach, Th ; Melichercik, J</creator><creatorcontrib>von Hodenberg, E ; Breidenbach, Th ; Melichercik, J</creatorcontrib><description>Patients with aortocoronary bypass surgery generelly have a severe, advanced coronary atherosclerosis. An intensive risk-factor management should be of special importance in these patients. However, cholesterol treatment goals are the same for operated or non-operated patients with coronary artery disease. Effective cholesterol lowering does not only decrease the progression of atherosclerosis in native coronary vessels but also helps to prevent the development of atherosclerosis in venous bypass grafts. Clinical studies demonstrated that this leads to an improvement of clinical endpoints. Unfortunately we know from registries, that even in bypass patients recommended guidelines for cholesterol lowering are often not followed.[PUBLICATION ABSTRACT]</description><identifier>ISSN: 1861-0684</identifier><identifier>EISSN: 1861-0692</identifier><identifier>DOI: 10.1007/s00392-006-1116-x</identifier><language>ger</language><publisher>Heidelberg: Springer Nature B.V</publisher><subject>Atherosclerosis ; Cardiovascular disease ; Coronary vessels</subject><ispartof>Clinical research in cardiology, 2006-01, Vol.95, p.i78</ispartof><rights>Steinkopff-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c752-b315dcf4a1b783ac7dc257527f2ce71f72deb6e4513f7db156159a1006d92f6a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>von Hodenberg, E</creatorcontrib><creatorcontrib>Breidenbach, Th</creatorcontrib><creatorcontrib>Melichercik, J</creatorcontrib><title>Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation</title><title>Clinical research in cardiology</title><description>Patients with aortocoronary bypass surgery generelly have a severe, advanced coronary atherosclerosis. An intensive risk-factor management should be of special importance in these patients. However, cholesterol treatment goals are the same for operated or non-operated patients with coronary artery disease. Effective cholesterol lowering does not only decrease the progression of atherosclerosis in native coronary vessels but also helps to prevent the development of atherosclerosis in venous bypass grafts. Clinical studies demonstrated that this leads to an improvement of clinical endpoints. Unfortunately we know from registries, that even in bypass patients recommended guidelines for cholesterol lowering are often not followed.[PUBLICATION ABSTRACT]</description><subject>Atherosclerosis</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><issn>1861-0684</issn><issn>1861-0692</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNo9T01LAzEQDaJgrf4Ab4v3aCbZJLtHWz-hoIfitWSTid22JGuyC_rvjSie5vFm3scQcgnsGhjTN5kx0XLKmKIAoOjnEZlBo4Ay1fLjf9zUp-Qs5x1jEpioZ-TtrsdqgQ6ncQrvlcNULbfxgHnE1IeMYf9Dd9hXr2bsMYwYqmDstjIxjXEfUwwmFdHiazA5xwFTOYvhnJx4c8h48TfnZP1wv14-0dXL4_PydkWtlpx2AqSzvjbQ6UYYq53lsiy05xY1eM0ddgprCcJr14FUIFtT_lWu5V4ZMSdXv7ZDih9TKb3ZxSmFkrhpGslqDsDFN1XtVDM</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>von Hodenberg, E</creator><creator>Breidenbach, Th</creator><creator>Melichercik, J</creator><general>Springer Nature B.V</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20060101</creationdate><title>Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation</title><author>von Hodenberg, E ; Breidenbach, Th ; Melichercik, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c752-b315dcf4a1b783ac7dc257527f2ce71f72deb6e4513f7db156159a1006d92f6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2006</creationdate><topic>Atherosclerosis</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>von Hodenberg, E</creatorcontrib><creatorcontrib>Breidenbach, Th</creatorcontrib><creatorcontrib>Melichercik, J</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Clinical research in cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>von Hodenberg, E</au><au>Breidenbach, Th</au><au>Melichercik, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation</atitle><jtitle>Clinical research in cardiology</jtitle><date>2006-01-01</date><risdate>2006</risdate><volume>95</volume><spage>i78</spage><pages>i78-</pages><issn>1861-0684</issn><eissn>1861-0692</eissn><abstract>Patients with aortocoronary bypass surgery generelly have a severe, advanced coronary atherosclerosis. An intensive risk-factor management should be of special importance in these patients. However, cholesterol treatment goals are the same for operated or non-operated patients with coronary artery disease. Effective cholesterol lowering does not only decrease the progression of atherosclerosis in native coronary vessels but also helps to prevent the development of atherosclerosis in venous bypass grafts. Clinical studies demonstrated that this leads to an improvement of clinical endpoints. Unfortunately we know from registries, that even in bypass patients recommended guidelines for cholesterol lowering are often not followed.[PUBLICATION ABSTRACT]</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s00392-006-1116-x</doi></addata></record>
fulltext fulltext
identifier ISSN: 1861-0684
ispartof Clinical research in cardiology, 2006-01, Vol.95, p.i78
issn 1861-0684
1861-0692
language ger
recordid cdi_proquest_journals_885042112
source SpringerLink Journals - AutoHoldings
subjects Atherosclerosis
Cardiovascular disease
Coronary vessels
title Die Bedeutung der Cholesterinsenkung bei Patienten nach aortokoronarer Bypassoperation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A45%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Die%20Bedeutung%20der%20Cholesterinsenkung%20bei%20Patienten%20nach%20aortokoronarer%20Bypassoperation&rft.jtitle=Clinical%20research%20in%20cardiology&rft.au=von%20Hodenberg,%20E&rft.date=2006-01-01&rft.volume=95&rft.spage=i78&rft.pages=i78-&rft.issn=1861-0684&rft.eissn=1861-0692&rft_id=info:doi/10.1007/s00392-006-1116-x&rft_dat=%3Cproquest%3E2434385451%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=885042112&rft_id=info:pmid/&rfr_iscdi=true